Sensius

Rotterdam, Netherlands · Founded 2015 · Privately Held (backing)

Developer of a thermotherapy system designed to improve treatment outcomes for head and neck cancer patients. Sensius is based in Rotterdam, Netherlands and was founded in 2015. Its last reported valuation was $44 million in May 2025. It has raised $21.5 million.

Last reported valuation
$44.0M
Oct 2026
Priced at
—
Total raised
$21.5M
Last round
—

Who backs Sensius?

14 investors
InvestorType
European Innovation CouncilVenture capital
European CommissionOther
UCEA Capital PartnersFamily office
Coöperatieve Rabobank.Other
Coöperatieve Rabobank—
EBAN (Brussels)—
EIT Health—
Erasmus MC Biomedical Fund—
European Innovation Council (Belgium)—
GrayBella Capital—
+ 4 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Sensius investors

14 investors are on record for Sensius, including European Innovation Council, European Commission, UCEA Capital Partners and Coöperatieve Rabobank..

Free account
More of Sensius with a free account
  • ·The complete investor list: 14 names
  • ·Watch Sensius: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 14 firms already write checks for companies like Sensius. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View